Allison Butenschon and Alexandra Moresco Join Fremedica Advisory Board
Allison Butenschon and Alexandra Moresco Join Fremedica Advisory Board
VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is pleased to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), has increased its team by adding two key roles. As Corporate Ambassador and Director of Business Development, Allison Butenschon will oversee development of opportunities now opened with expansion of our rights. Alexandra Moresco becomes our PR and Social Media director responsible for growing NIKKI awareness and demand across all of our communications platforms.
不列顛哥倫比亞省溫哥華/ACCESSWIRE/2023年11月20日/頻率交換公司（“頻率交易所” 或 “公司”）（TSXV: FREQ）欣然宣佈，其全資子公司FreMedica Technologies Inc.（“Fremedica”）增加了兩個關鍵職位，從而擴大了團隊。作爲企業大使兼業務發展總監，艾莉森·布滕申將監督隨着權利的擴大而開闢的機會的發展。Alexandra Moresco成爲我們公關和社交媒體總監，負責提高我們所有傳播平台上的NIKKI知名度和需求。
|
Allison Butenschon Director of Business Development |
|
| Allison Butenschon is an entrepreneur with a diverse and colourful career. Her health and wellness journey began with a personal battle against Lyme disease contracted at age 18. This challenging experience shaped her life and inspired her to help others facing similar emotional and physical devastation. Despite her disease, Allison has made significant contributions as a clothing, interior and lifestyle designer. She has also been instrumental in commercial and residential building development, demonstrating her business skills as an innovative thinker and leader. With her unique blend of expertise in alternative health, design, and business development, Allison continues to inspire and empower individuals to overcome adversity and pursue their dreams. |
| 艾莉森·布滕舍恩 業務發展總監 |
|
| 艾莉森·布滕舍恩是一位擁有豐富多彩職業生涯的企業家。她的健康和保健之旅始於與18歲時感染的萊姆病的個人鬥爭。這種充滿挑戰的經歷塑造了她的生活，激發了她幫助其他面臨類似情感和身體創傷的人的靈感。儘管她患有疾病，但作爲服裝、室內設計和生活方式設計師，艾莉森還是做出了重大貢獻。她還在商業和住宅建築開發方面發揮了重要作用，展示了她作爲創新思想家和領導者的商業技能。憑藉她在替代健康、設計和業務發展方面的獨特專業知識，艾莉森繼續激勵和增強個人克服逆境和追求夢想的能力。 |
Allison Butenschon states "Nikki has been life-altering for myself and my family. After circling the drain with chronic Lyme for over 15 years with little to no improvement, this device fell in our laps from a friend desperately trying to help us get better. I'm not only out of bed and back to life; I'm thriving. I'll never be without NIKKI again. It has given me my life back."
艾莉森·布滕舍恩說：“Nikki改變了我自己和我的家人的生活。在患有慢性萊姆病超過15年之後，該設備幾乎沒有改善，但從一位拼命試圖幫助我們康復的朋友手中掉到了我們的圈子裏。我不僅起牀重獲新生；我正在蓬勃發展。我再也沒有 NIKKI 了。它讓我恢復了生活。”
FREmedica President Nicole Sullivan, states "Having individuals of Allison's quality and experience join us as we launch NIKKI along new paths is very encouraging. Allison was drawn to us through her experience with our Lyme Frequency Set. Her family members got their lives back after a 15-year battle with Lyme disease. We welcome Allison to our team knowing she will be a major contributor to our success."
FreMedica總裁妮可·沙利文表示：“讓像艾莉森這樣素質和經驗的人加入我們，走上新的道路，讓NIKKI走上新的道路，這非常令人鼓舞。艾莉森之所以被我們吸引，是因爲她對萊姆頻率設置的體驗。在與萊姆病抗爭了15年之後，她的家人恢復了生活。我們歡迎艾莉森加入我們的團隊，因爲她知道她將爲我們的成功做出重要貢獻。”
|
Alexandra Moresco Public Relations and Social Media Director |
|
| When Alexandra was stricken with Lyme disease, she shifted the focus of her entertainment and talent relations company to helping other Lyme sufferers and creating partnerships to find a cure. With degrees in public relations, advertising and journalism, she adds her personal experience living with chronic disease to build long-lasting relations with both media and patient communities. Alexandra works with companies including Nike, Complex Magazine and Facebook Watch-now, boasting a client roster of top tier medical, healthcare and wellness clients. She has raised hundreds of thousands of dollars for tick-borne illness research and over the past year has secured over 250 prominent placements with media readership equating to a billion viewers. |
| 亞歷山德拉·莫雷斯科 公共關係和社交媒體總監 |
|
| 當亞歷山德拉患有萊姆病時，她將娛樂和人才關係公司的重點轉移到了幫助其他萊姆病患者和建立合作伙伴關係以尋找治療方法上。她擁有公共關係、廣告和新聞學學位，結合自己患有慢性病的親身經歷，與媒體和患者社區建立了長期的關係。亞歷山德拉與耐克、Complex Magazine和Facebook Watch-Now等公司合作，擁有頂級醫療、醫療保健和保健客戶的客戶名單。她爲蜱傳疾病研究籌集了數十萬美元，在過去的一年中，她獲得了250多個知名度排名，媒體讀者人數相當於10億觀衆。 |
"As a health-focused public relations company, we are excited to partner with NIKKI to create greater awareness of innovative technologies that are having a profound impact on improving wellness and speeding recovery." States Ali Moresco, founder, Moresco Public Relations and Communications
“作爲一家專注於健康的公共關係公司，我們很高興能與NIKKI合作，提高人們對創新技術的認識，這些技術對改善健康和加速康復具有深遠影響。”莫雷斯科公共關係與傳播部創始人阿里·莫雷斯科說
Nicole Sullivan, President of FREmedica states "Allison and Alexandra bring a wealth of knowledge and passion to Fremedica together with a deeper understanding for our NIKKI users based on their personal health journeys. They are very welcome additions to our team, and I am looking forward to seeing them develop our brand awareness and expand our reach."
FreMedica總裁妮可·沙利文表示：“艾莉森和亞歷山德拉爲Fremedica帶來了豐富的知識和激情，並根據我們的NIKKI用戶的個人健康歷程對他們有了更深入的了解。他們是我們團隊中非常受歡迎的新成員，我期待看到他們提高我們的品牌知名度並擴大我們的影響力。”
NIKKI is a first-of-its-kind wearable frequency delivery system; a wellness centre on your wrist that delivers frequency sets on demand into the body designed to enhance wellness and improve performance. NIKKI is now offered as NIKKI-Lyme to help speed recovery from the fastest-growing vector-borne disease in North America.
NIKKI 是同類產品中首款可穿戴頻率傳輸系統；它是您手腕上的健康中心，可按需向身體提供頻率設置，旨在增強健康和改善表現。NIKKI現在以Nikki-Lyme的名義出現，以幫助加快從北美增長最快的媒介傳播疾病中恢復過來。
About the Company
關於本公司
Based in British Columbia, Canada, the company is focused on the development and global commercialization of a wearable frequency delivery system delivering specialized frequency sets designed to enhance wellness and improve performance. NIKKI is the fifth-generation frequency delivery system and third wearable technology created by the Company, initially to help clients with chronic Lyme disease. This wearable technology combined with the frequency sets is the result of years of research and development using advanced bioenergetic technology.
該公司總部位於加拿大不列顛哥倫比亞省，專注於可穿戴頻率傳輸系統的開發和全球商業化，該系統提供旨在增強健康和改善性能的專用頻率集。NIKKI 是公司開發的第五代頻率傳輸系統和第三款可穿戴技術，最初用於幫助患有慢性萊姆病的客戶。這種可穿戴技術與頻率設置相結合，是多年來使用先進的生物能技術進行研究和開發的結果。
For more information, please contact:
欲了解更多信息，請聯繫：
Frequency Exchange Corp.
FREmedica Technologies
頻率交換公司
FreMedica 科技
Stephen Davis CEO and Director
250-732-7170
Nicole Sullivan. President
nicole@fremedica.com
斯蒂芬·戴維斯首席執行官兼董事
250-732-7170
妮可沙利文。主席
nicole@fremedica.com
Cautionary Note Regarding Forward-Looking Information
關於前瞻性信息的警示說明
Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the trading date of the Company's common shares on the Exchange. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
根據加拿大證券法，此處包含的某些信息構成 “前瞻性信息”。前瞻性信息包括但不限於有關公司在聯交所的普通股交易日期的陳述。通常，可以通過使用前瞻性術語來識別前瞻性信息，例如 “意志”，或者某些行動、事件或結果 “將” 發生的詞語和短語或陳述的變體。前瞻性陳述基於管理層截至此類陳述發表之日的意見和估計，受已知和未知的風險、不確定性和其他因素的影響，這些因素可能導致實際結果與此類前瞻性陳述或前瞻性信息所表達或暗示的結果存在重大差異。無法保證此類陳述會被證明是準確的，因爲實際結果和未來事件可能與此類聲明中的預期存在重大差異。讀者不應過分依賴前瞻性陳述和前瞻性信息。除非適用的證券法要求，否則公司不會更新此處以引用方式納入的任何前瞻性陳述或前瞻性信息。
Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company's profile on SEDAR at .
識別風險和不確定性的其他信息包含在公司向加拿大證券監管機構提交的文件中，這些文件可在SEDAR上的公司簡介下查閱，網址爲。
Neither the Exchange nor its Regulation Services Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
交易所及其監管服務提供商（該術語在交易所政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
SOURCE: Frequency Exchange Corp.
來源：頻率交換公司
譯文內容由第三人軟體翻譯。